您的位置: 首页 > 农业专利 > 详情页

COMPOSITION POUR ATTÉNUER, PRÉVENIR OU TRAITER UN TROUBLE DU SOMMEIL OU COMPOSITION POUR SUPPRIMER LA RÉSISTANCE À UN AGONISTE DU SITE DE LIAISON AUX BENZODIAZÉPINES DU RÉCEPTEUR GABA-A, OU POUR ATTÉNUER UN EFFET SECONDAIRE D'UN AGONISTE DU SITE DE LIAISON AUX BENZODIAZÉPINES DU RÉCEPTEUR GABA-A, CHAQUE COMPOSITION COMPRENANT DU PHLOROGLUCINOL EN TANT QUE PRINCIPE ACTIF
专利权人:
Korea Food Research Institute
发明人:
申请号:
EP18797671.7
公开号:
EP3622949A1
申请日:
2018.05.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to a pharmaceutical composition for preventing or treating somnipathy including phloroglucinol as an active ingredient and a health functional food composition for ameliorating somnipathy including phloroglucinol as an active ingredient. The pharmaceutical composition and the health functional food composition according to the present invention rapidly and reliably induce and maintain sleep, prevent repeated awakenings, unalter physiological sleep architecture, are particularly devoid of residual sedative effects, which could impair daytime functioning and cognitive performance, do not cause tolerance to a conventional agonist at the benzodiazepine binding site of the GABA-A receptor despite long-term administration, and do not cause side effects of a conventional agonist at the benzodiazepine binding site of the GABA-A receptor. The present invention also relates to a pharmaceutical composition for suppressing tolerance to or alleviating side effects of an agonist at the benzodiazepine binding site of the GABA-A receptor including phloroglucinol as an active ingredient and a health functional food composition for suppressing tolerance to or ameliorating side effects of an agonist at the benzodiazepine binding site of the GABA-A receptor including phloroglucinol as an active ingredient. The pharmaceutical composition and the health functional food composition according to the present invention can alleviate side effects of the agonist or can suppress tolerance to the agonist resulting from long-term administration. The present invention also relates to a pharmaceutical composition for preventing or treating somnipathy including phloroglucinol and an agonist at the benzodiazepine binding site of the GABA-A receptor as active ingredients. The pharmaceutical composition of the present invention uses a reduced amount of the agonist, which may increase the amount of sleep but degrade the quality of sleep to cause various side effects, to all
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充